Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-22,086
Closed -$5.29M 71
2020
Q3
$5.29M Buy
22,086
+533
+2% +$132K 3.07% 19
2020
Q2
$5.25M Sell
21,553
-40
-0.2% -$9.13K 3.24% 15
2020
Q1
$4.38M Sell
21,593
-584
-3% -$128K 3.99% 10
2019
Q4
$4.92M Sell
22,177
-65
-0.3% -$14.3K 3.01% 18
2019
Q3
$4.51M Buy
22,242
+240
+1% +$46.1K 3.05% 18
2019
Q2
$3.83M Buy
22,002
+2,952
+15% +$529K 2.71% 20
2019
Q1
$3.62M Sell
19,050
-68
-0.4% -$13K 2.77% 16
2018
Q4
$3.6M Buy
+19,118
New +$3.73M 2.82% 17

Other funds holding AMGN

Miramar Capital's AMGN Position: Q4 2020 in Review

Miramar Capital sold out of Amgen (AMGN) in Q4 2020, closing a stake of 22,086 shares — an estimated $5.29M sold.

Miramar Capital first reported a position in AMGN in Q4 2018 and held it in 8 quarters. The position peaked at $5.29M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Miramar Capital reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Miramar Capital sold 22,086 Amgen shares in Q4 2020, an estimated $5.29M.
  • Miramar Capital first reported a position in Amgen in Q4 2018 and held it in 8 quarters.
  • Miramar Capital's Amgen position peaked at $5.29M in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Miramar Capital's 13F filing for Q4 2020, filed 9 Feb 2021.